Anika Therapeutics Inc. (ANIK): Market Cap to Revenue

Symbol and logo of brand Anika (ANIK)

Anika Therapeutics relies on unique joint-preserving injections, which provide the company with a competitive market advantage. Business efficiency is supported by outsourced manufacturing and global logistics. However, insurance reimbursement limits are constraining pricing power. P/S volatility confirms these fundamental aspects, and 1.40 expresses the metric's value today, capturing the current investor consensus on revenue valuation.

ANIK Anika P/S Multiple (07/04/2022 - 11/17/2026)

Analytical breakdowns for Anika Therapeutics Inc. (ANIK)

- share price and consensus valuation forecast:
General company analysis:ANIK Anika Therapeutics
Core merchandise of Anika Therapeutics, Inc.

Investors are assessing the resilience of Anika Therapeutics (ANIK) through the market capitalization-to-annual revenue ratio, which determines the value of each dollar of sales. By analyzing the price-to-sales multiple history, one can understand how effectively the medical device component outsourcing model converts into market value, avoiding overpaying for the asset during periods of unjustified price peaks.

Competitors of Anika Therapeutics

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)